Pliant Therapeutics, Inc.
PLRXNasdaqCIK 1746473HealthcareFiscal year ends Dec 31
Reports and events: 104 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000115 |
| 2026-08-1120:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001746473-26-000113 |
| 2026-07-1320:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-26-000107 |
| 2026-06-1120:52 ET | 8-K | 5.07 Shareholder vote results | 0001746473-26-000092 |
| 2026-05-1120:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001746473-26-000090 |
| 2026-05-1120:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000088 |
| 2026-04-2220:30 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001746473-26-000076 |
| 2026-04-1720:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-26-000050 |
| 2026-03-3021:38 ET | 8-K | 8.01 Other events | 0001746473-26-000046 |
| 2026-03-1120:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-26-000039 |
| 2026-03-1120:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001746473-26-000037 |
| 2026-03-0321:35 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001746473-26-000024 |
| 2025-12-1622:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-25-000182 |
| 2025-12-0821:41 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-25-000179 |
| 2025-11-0621:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001746473-25-000175 |
| 2025-11-0621:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000173 |
| 2025-10-2420:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001746473-25-000159 |
| 2025-10-2020:31 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-243619 |
| 2025-08-0720:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001746473-25-000150 |
| 2025-08-0720:16 ET | 8-K | 9.01 Financial statements and exhibits | 0001746473-25-000149 |
| 2025-06-0921:29 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001746473-25-000105 |
| 2025-05-0820:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001746473-25-000099 |
| 2025-05-0820:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000097 |
| 2025-05-0120:13 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-25-109976 |
| 2025-04-2320:17 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001746473-25-000089 |
| 2025-03-1312:49 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-053541 |
| 2025-03-1021:24 ET | SCHEDULE 13D | Ownership report, active investor | 0001214659-25-004133 |
| 2025-03-0321:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001746473-25-000054 |
| 2025-03-0321:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-25-000051 |
| 2025-02-1314:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-025663 |
| 2025-02-1012:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-023130 |
| 2024-11-0721:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001746473-24-000171 |
| 2024-11-0721:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000169 |
| 2024-09-2720:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001746473-24-000153 |
| 2024-08-0720:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001746473-24-000145 |
| 2024-08-0720:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000143 |
| 2024-07-1515:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-178937 |
| 2024-06-1420:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001746473-24-000084 |
| 2024-05-1411:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-137731 |
| 2024-05-0620:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001746473-24-000076 |
| 2024-05-0620:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000073 |
| 2024-04-2220:58 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001746473-24-000057 |
| 2024-03-1211:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-065416 |
| 2024-02-2721:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001746473-24-000043 |
| 2024-02-2721:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-24-000041 |
| 2024-02-0512:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-023459 |
| 2023-11-0921:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001746473-23-000074 |
| 2023-11-0921:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001746473-23-000072 |
| 2023-10-0320:53 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001746473-23-000062 |
| 2023-09-2611:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-241849 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.